{
    "data": [
        {
            "Project Code": 7387,
            "Project Name/ Brief Description": "Human Microbiome",
            "Full Description": "Study of microbial communities that life in and on our bodies and the role they play in disease",
            "Owner": "Fred Patrick",
            "Status": "ONGOING"
        },
        {
            "Project Code": 8514,
            "Project Name/ Brief Description": "PDE4 Inhibitors",
            "Full Description": "Small molecules for proposed treatment of Dermatitis",
            "Owner": "Bennie Bowers",
            "Status": "CLOSED"
        },
        {
            "Project Code": 8364,
            "Project Name/ Brief Description": "TNF Inhibitors",
            "Full Description": "Small molecules for proposed treatment of Rheumatoid Arthritis",
            "Owner": "Rickey Page",
            "Status": "ONGOING"
        },
        {
            "Project Code": 4309,
            "Project Name/ Brief Description": "JAK3 Specific Inhibitors",
            "Full Description": "Auto-immune disease focus",
            "Owner": "Clayton Wagner",
            "Status": "ONGOING"
        },
        {
            "Project Code": 5823,
            "Project Name/ Brief Description": "GSK3b Inhibitors",
            "Full Description": "Development of selective inhibitors for AD and Bipolar disorder platforms",
            "Owner": "Sharon Boone",
            "Status": "ONGOING"
        },
        {
            "Project Code": 8841,
            "Project Name/ Brief Description": "Beta-Arrestin Biased Inhibitors",
            "Full Description": "For selective modulation of GPCRs for improved disease treatments",
            "Owner": "Patrick Mathis",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9278,
            "Project Name/ Brief Description": "Anti PD-L1 Biologics",
            "Full Description": "Oncology: Renal cell carcinoma combo treatment",
            "Owner": "Cathy Gill",
            "Status": "ONGOING"
        },
        {
            "Project Code": 8897,
            "Project Name/ Brief Description": "ER+/HER2+ B. Cancer",
            "Full Description": "Small molecule development for CDK4,6 Kinase Inhibitors",
            "Owner": "Clint Gonzales",
            "Status": "ONGOING"
        },
        {
            "Project Code": 5859,
            "Project Name/ Brief Description": "ALK Inhibitors",
            "Full Description": "To target Non-Small Cell lung cancer",
            "Owner": "Roger Reyes",
            "Status": "ONGOING"
        },
        {
            "Project Code": 4256,
            "Project Name/ Brief Description": "Group B Streptococcus",
            "Full Description": "Prophylactic vaccine development",
            "Owner": "Donnie Patterson",
            "Status": "ONGOING"
        },
        {
            "Project Code": 4915,
            "Project Name/ Brief Description": "RSV (Respiratory Syncytial Virus)",
            "Full Description": "Prophylactic vaccine development",
            "Owner": "Lionel Morris",
            "Status": "CLOSED"
        },
        {
            "Project Code": 6396,
            "Project Name/ Brief Description": "sGC Stimulators (soluble Guanylate Cyclase)",
            "Full Description": "Investigate stimulators for protection against worsening chronic heart failure",
            "Owner": "Harvey Bowen",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9116,
            "Project Name/ Brief Description": "Anti-infectives (Bacteria)",
            "Full Description": "Class A and C beta-lactamase inhibitors for treatment of acute bacterial infections",
            "Owner": "Ada Bryant",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9044,
            "Project Name/ Brief Description": "LPA1 Antagonists",
            "Full Description": "Small molecule discovery for Fibrotic diseases",
            "Owner": "Shelly Myers",
            "Status": "ONGOING"
        },
        {
            "Project Code": 6100,
            "Project Name/ Brief Description": "PEG-FGF21",
            "Full Description": "Pegbelfermin - Biologic discovery for Fibrotic diseases",
            "Owner": "Amos Mills",
            "Status": "ONGOING"
        },
        {
            "Project Code": 6694,
            "Project Name/ Brief Description": "TYK2 Inhibitors",
            "Full Description": "Small molecule discovery for treatment of Psoriasis, Rheumatoid Arthritis",
            "Owner": "Emily Klein",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9148,
            "Project Name/ Brief Description": "BTK Inhibitors",
            "Full Description": "Small molecule discovery for Immunoscience",
            "Owner": "Vanessa Knight",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9151,
            "Project Name/ Brief Description": "S1P1 Agonists",
            "Full Description": "Small molecule discovery for Sphingosine-1-phosphate receptor - MS",
            "Owner": "Sylvia Patton",
            "Status": "ONGOING"
        },
        {
            "Project Code": 4639,
            "Project Name/ Brief Description": "TLR 7/8 Antagonists",
            "Full Description": "Small molecule discovery for Immunoscience",
            "Owner": "Jeannette Rios",
            "Status": "ONGOING"
        },
        {
            "Project Code": 9939,
            "Project Name/ Brief Description": "Anti-TIM-3",
            "Full Description": "Monoclonal antibody treatment for Oncology",
            "Owner": "Alex Dixon",
            "Status": "ONGOING"
        },
        {
            "Project Code": 5466,
            "Project Name/ Brief Description": "NLRP3 Agonists",
            "Full Description": "Small molecule discovery for Oncology",
            "Owner": "Julius Salazar",
            "Status": "CLOSED"
        },
        {
            "Project Code": 6192,
            "Project Name/ Brief Description": "HIVI",
            "Full Description": "HIV integrase inhibitor",
            "Owner": "Neal Welch",
            "Status": "ONGOING"
        },
        {
            "Project Code": 1182,
            "Project Name/ Brief Description": "PARP 1/2 Inhibitor",
            "Full Description": "Poly (ADP-ribose) 1/2 Inhibitors targeting ovarian cancer - monotherapy",
            "Owner": "Ruben Caldwell",
            "Status": "ONGOING"
        },
        {
            "Project Code": 6776,
            "Project Name/ Brief Description": "ADRB2 Agonists",
            "Full Description": "Beta 2 adrenergic receptor agonist as component of dual treatment with muscarinic receptor antagonist - Asthma",
            "Owner": "Glen Pierce",
            "Status": "ONGOING"
        },
        {
            "Project Code": 8325,
            "Project Name/ Brief Description": "IL5 Antagonists",
            "Full Description": "Interleukin 5 antagonists for targeting Hypereosinophilic Syndrome",
            "Owner": "Camille Weber",
            "Status": "ONGOING"
        },
        {
            "Project Code": 229,
            "Project Name/ Brief Description": "CXCR4 Inhibitors",
            "Full Description": "alpha-chemokine receptor specific for stromal-derived factor 1 (SDF-1)",
            "Owner": "Neal Welch",
            "Status": "ONGOING"
        }
    ],
    "paging": {
        "total": 26
    }
}
